Dermatological Use
Ivermectin is an antiparasitic agent derived and synthesized from soil.
The ingredient was developed in the late 1970’s and first approved by the FDA in 1987 as a skincare treatment for parasitic infections. It gained similar approval in the UK in 1988.
Ivermectin introduced an effective prescription topical treatment for managing rosacea, reshaping dermatological outcomes for inflammatory and parasitic skin concerns.
Menu 
